Perrigo Recalls Infant Acetaminophen Liquid With Blank Dosing Syringe
This article was originally published in The Tan Sheet
The private labeler initiated a retail-level nationwide recall of acetaminophen infant suspension liquid, 160 mg/5 mL, sold in 2- and 4-ounce bottles with syringes because of the “remote potential that a small number of packages might contain an oral dosing syringe without dose markings.”
You may also be interested in...
CHPA urges FDA not to wait until it publishes the final internal analgesics, antipyretic and anti-rheumatic monograph before allowing manufacturers to label acetaminophen products with dosing information for children 6 months to 2 years old. In a citizen petition, the trade group proposes FDA publish a statement of enforcement policy expressly permitting the use of a standardized age- and weigh-based dosing chart.
McNeil Consumer Healthcare recalls an Infants’ Tylenol product that returned to market in November, after receiving consumer complaints about a problem with the SimpleMeasure dosing device system. The recall marks a misstep in the J&J subsidiary’s comeback from OTC quality control issues.
Perrigo quality control managers emphasize immediate investigations of low-risk incidents and forward-looking remediation in the firm’s new corrective and preventive actions strategy.